Dr Olivia Quintos, MD | |
17207 Kuykendahl Rd, Suite 200, Spring, TX 77379-8423 | |
(832) 698-5320 | |
Not Available |
Full Name | Dr Olivia Quintos |
---|---|
Gender | Female |
Speciality | Anesthesiology |
Location | 17207 Kuykendahl Rd, Spring, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104814391 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | E5895 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Olivia Quintos, MD 17207 Kuykendahl Rd, Suite 200, Spring, TX 77379-8423 Ph: (832) 698-5320 | Dr Olivia Quintos, MD 17207 Kuykendahl Rd, Suite 200, Spring, TX 77379-8423 Ph: (832) 698-5320 |
News Archive
Magnetic Resonance Imaging (MRI) is a radiology study used to help diagnose a variety of injuries and illness, including headaches and head injuries. For patients with headaches and those sensitive to sound, the audible noise during the actual test may be mildly annoying or downright stressful.
For the first time, scientists have demonstrated that stem cells found in amniotic fluid meet an important test of potential to become specialized cell types, which suggests they may be useful for treating a wider array of diseases and conditions than scientists originally thought.
Today the Centers for Disease Control and Prevention (CDC) announced the start of National Influenza Vaccination Week. While the week was designed to highlight the importance of flu vaccinations, it also brings to light the importance of taking additional steps to keep you and your family healthy during the peak cold and flu season of December, January and beyond.
Wilmington Pharmaceuticals announced today the U.S. Food and Drug Administration (FDA) has granted marketing approval for METOZOLV ODT (metoclopramide HCl), an orally disintegrating formulation of metoclopramide for the treatment of gastroesophageal reflux disease (GERD) and diabetic gastroparesis.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has advanced miravirsen (SPC3649), the first microRNA-targeted drug to enter clinical trials, into Phase 2 studies to assess the safety and tolerability of the drug in treatment-naive patients infected with the Hepatitis C virus.
› Verified 4 days ago
Dr. Ju Kuang, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 17207 Kuykendahl Rd, Suite 200, Spring, TX 77379 Phone: 832-698-5320 | |
Dr. Soudip Saha, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 21227 Fernhollow Ln, Spring, TX 77388 Phone: 805-290-0129 | |
Dr. Hansa Mehta, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 17207 Kuykendahl Rd, Suite 200, Spring, TX 77379 Phone: 832-698-5320 | |
Dr. Timothy Osborn, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 17207 Kuykendahl Rd, Suite 200, Spring, TX 77379 Phone: 832-698-5320 | |
Dr. Roger Rankin, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 17207 Kuykendahl Rd, Suite 200, Spring, TX 77379 Phone: 832-698-5320 | |
Yo Jin Yoon, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 17207 Kuykendahl Rd Ste 220, Spring, TX 77379 Phone: 832-698-5331 |